D
Crinetics Pharmaceuticals, Inc. CRNX
$34.47 -$0.57-1.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -39.10% -39.36% -40.59% -34.33% -30.88%
Total Depreciation and Amortization 153.64% 102.42% 61.50% 25.63% 11.70%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 48.46% 67.47% 72.92% 60.43% 34.21%
Change in Net Operating Assets 44.64% 858.98% 492.09% 167.96% -56.78%
Cash from Operations -35.88% -22.58% -11.36% -25.33% -44.36%
Capital Expenditure 18.00% 6.88% -456.00% -278.80% -183.09%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -191.72% -61.01% -361.61% -202.60% -13.58%
Cash from Investing -186.82% -57.42% -369.59% -204.08% -15.19%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 157.45% 37.45% 5,453.26% 538.96% 217.36%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -117.47% 16.19% -12,296.43% -396.84% -193.05%
Cash from Financing 159.79% 40.78% 5,306.21% 548.09% 218.90%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 843.34% 55.94% 1,296.94% 442.56% 113.29%
Weiss Ratings